Biotechnology

RepliCel Announces Appointment of Leading Sports Medicine Expert as Orthopedics Clinical Advisor (Japan)

May 3, 2021 6:00 AM

Professor Tsukasa Kumai, member of the Japan's Olympic Committee Medical and Scientific Staff, will lead RepliCel's Tendon Regeneration Clinical Testing in Japan VANCOUVER, BC / ACCESSWIRE / May 3, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ("RepliCel" or the "Company"), a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce that Professor Tsukasa Kumai, one of...

Read more

Binovi Completes Motion Tracking Software Acquisition

April 30, 2021 4:00 PM

VANCOUVER, BC / ACCESSWIRE / April 30, 2021 / Binovi Technologies Corp. ("Binovi" or the "Company') (TSXV:VISN)(OTCQB:BNVIF)(GR:2EYA) a leader in neuro-vision performance technology, is pleased to announce that further to its news release dated April 16, 2021, the Company has completed the acquisition of all the issued and outstanding share capital of Samurai Motion Tracking Software (the "Acquisition") and thereby the assets of computer aided...

Read more

Dyadic to Report First Quarter 2021 Financial Results

April 29, 2021 4:00 PM

JUPITER, FL / ACCESSWIRE / April 29, 2021 / Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ:DYAI), a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, today announced that it will report its...

Read more

Calyxt Successfully Transforms Hemp Genome

April 29, 2021 8:31 AM

New Hemp Transformation Technology Unlocks Capabilities to Selectively Breed and Deliver Improvements in Hemp Traits for Key Markets Including Protein, Fiber, Advanced Materials and Wellness Patent-Pending Transformation Process is Calyxt's First Announced Innovation in a Broad Hemp Improvement Pipeline ROSEVILLE, MN / ACCESSWIRE / April 29, 2021 / Calyxt, Inc. (NASDAQ:CLXT), a plant-based technology company, announced today that it has...

Read more

RepliCel Closes Second Tranche of Strategic Investment Commitment

April 29, 2021 6:00 AM

MainPointe Pharmaceuticals Completes Largest Scheduled Share Purchases per Investment Agreement VANCOUVER, BC / ACCESSWIRE / April 29, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF) (TSXV:RP) (FRA:P6P2) ("RepliCel" or the "Company"), a company developing next-generation technologies in aesthetics and orthopedics, announced today it has closed the second tranche of the investment by MainPointe Pharmaceuticals ("MainPointe") as outlined in...

Read more

Experion Holdings Reports Record Revenue and First Quarter of Positive Adjusted EBITDA

April 28, 2021 4:30 PM

VANCOUVER, BC / ACCESSWIRE / April 28, 2021 / Experion Holdings Ltd. (the "Company" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31), Canada's solution to craft cannabis supply and builder of premium cannabis brands including its sought after and popular brand Citizen Stash is pleased to report its first-quarter financial results for the three-month period ended February 28, 2021. Mr. Jarrett Malnarich, CEO of Experion stated, "This was...

Read more

Apollo Endosurgery to Report First Quarter Financial Results on May 4, 2021

April 28, 2021 8:00 AM

AUSTIN, TX / ACCESSWIRE / April 28, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release its financial results for the first quarter ended March 31, 2021 on Tuesday, May 4, 2021 after the market closes. In conjunction with the release, Apollo will host a conference call...

Read more

Tetra Bio-Pharma Submits Request for Scientific Advice to Malta Medicines Authority

April 28, 2021 2:00 AM

Tetra plans for global commercialization of QIXLEEF OTTAWA, ON / ACCESSWIRE / April 28, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP)(OTCQB:TBPMF)(FRA:JAM1), a leader in cannabinoid-derived drug discovery and development announced today that it has submitted a request to the Malta Medicines Authority for a Scientific Opinion on its investigational new drug (IND) QIXLEEF for Tetra's clinical trial programs. This request...

Read more

Vitro Biopharma Inc. January 31st 2021, 1st Quarter ended Financial Results of Operations and Shareholder Letter

April 27, 2021 6:00 PM

GOLDEN, CO / ACCESSWIRE / April 27, 2021 / Vitro Biopharma Inc. (formerly Vitro Diagnostics Inc.) (dba Vitro Biopharma), announced its quarter ended January 31st, 2021, financial results of operations. Vitro Biopharma recorded quarter ended January 31st, 2021 revenues of $ 127,492 vs $225,921 a decrease of 44% over the prior comparative quarter directly attributed to the COVID-19 pandemic. Revenues in the first quarter of 2021 of $127,492...

Read more

Invest Africa Global Receives Its First Covid-19 Rapid Test Kit In Namibia, Africa

April 27, 2021 7:30 AM

Invest Africa Global Receives Its First Covid-19 Rapid Test Kit In Namibia, Africa CHEYENNE, WY / ACCESSWIRE / April 27, 2021 / MJ Biotech, Inc. (OTC PINK:MJTV), the first shipment to Invest Africa Global of Covid 19 Rapid Test Kit arrived at Namibia, Africa April 23, 2021. The Rapid Test kit is a Nasal Swab test that produces test results in 10 minutes. This is an exciting time for the Company and for Invest Africa Global, as well. The next...

Read more

Experion to Present at the Emerging Growth Conference on April 28, 2021

April 26, 2021 8:45 AM

VANCOUVER, BC / ACCESSWIRE / April 26, 2021 / Experion Holdings Ltd. (the "Company" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) Canada's solution to craft cannabis supply and builder of premium cannabis brands including its sought after and popular brand Citizen Stash announced today that its CEO, Mr. Jarrett Malnarich, has been invited to present live at the Emerging Growth Conference on April 28, 2021. Experion invites...

Read more

Kinarus Further Strengthens Its Leadership with Two Reputed Industry Experts

April 26, 2021 8:00 AM

Hari Kumar, former CEO of Adheron Therapeutics, Inc. appointed Chairman of the Board of Directors Thierry Fumeaux, MD, former member of Swiss National Covid Taskforce, joined Kinarus as new Chief Medical Officer BASEL, SWITZERLAND / ACCESSWIRE / April 26, 2021 / Kinarus AG, a Swiss clinical-stage biopharmaceutical company and owner of KIN001, a differentiated therapeutic candidate for the treatment of multiple diseases with high unmet...

Read more

Nascent Biotech Announces Pre-emptive Elimination of Significant Tranche of Convertible Debt

April 26, 2021 8:00 AM

SAN DIEGO, CA / ACCESSWIRE / April 26, 2021 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology company pioneering the development of monoclonal antibodies targeting treatment of various cancers and viral infections, is pleased to announce that It has paid off and eliminated a major convertible debt note, pre-emptively preventing a dilutive conversion. The note, which was held...

Read more

Pieris Pharmaceuticals and Boston Pharmaceuticals Enter into an Exclusive Worldwide Product License for PRS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific

April 26, 2021 8:00 AM

Pieris will receive $10 million upfront and be entitled to receive additional milestone payments and tiered royalties Boston Pharmaceuticals will be primarily responsible for development of the program, with both parties collaborating during the investigational new drug (IND)-enabling stage BOSTON and CAMBRIDGE, MA / ACCESSWIRE / April 26, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) and Boston Pharmaceuticals today announced that...

Read more

Hancock Jaffe Principal Investigator Dr. Jorge Hernando Ulloa Presents VenoValve One Year First-In-Human Data at Charing Cross International Symposium

April 23, 2021 12:40 PM

IRVINE, CA / ACCESSWIRE / April 23, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that Dr. Jorge Hernando Ulloa, the Principal Investigator for HJLI's first-in-human VenoValve® study in Bogota, Colombia, presented one year data this past week at the Charing Cross International Symposium. The Charing Cross International Symposium is the...

Read more

Tetra Bio-Pharma Provides an Update on its U.S. REBORN1 Clinical Trial

April 23, 2021 9:00 AM

First clinical study to assess cannabis as an alternative to morphine Tetra completes manufacturing of QIXLEEF clinical trial drug for REBORN1 trial Export permit received from Health Canada for immediate shipping to USA OTTAWA, ON / ACCESSWIRE / April 23, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP)(OTCQB:TBPMF)(FRA:JAM1), a leader in cannabinoid-derived drug discovery and development is pleased to announce that...

Read more

THC Therapeutics Has Completed the dHydronator(R) Consumer Model Design

April 23, 2021 8:33 AM

THCT has leveraged the extensive market research commissioned through Keyhole Research to redesign the dHydronator® for the consumer market. This new design is in the rapid prototyping phasein preparation for mass manufacturing. LAS VEGAS, NV / ACCESSWIRE / April 23, 2021 / THC Therapeutics, Inc. (OTC PINK:THCT), a forward-thinking, publicly-traded technology company, whose mission statement is, "Better Health through the Science of...

Read more

ITOCO Welcomes Mr. Hadelin Carlos Diericx Trouyet to Its Board of Directors

April 23, 2021 8:00 AM

TORONTO, ON / ACCESSWIRE / April 23, 2021 / ITOCO INC. (OTC PINK:ITMC) is pleased to announce that Mr. Hadelin Carlos Diericx Trouyet has joined the firm's Board of Directors. Mr. Diericx is a results-driven, highly-accomplished, and focused serial entrepreneur with 25 years of experience. He brings strong leadership skills, dedication and discipline, with broad experience in business development. He charted growth paths for several...

Read more

Molecular Partners Files Registration Statement for Proposed Initial Public Offering in the United States

April 23, 2021 1:00 AM

ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / April 23, 2021 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company that is developing a new class of custom-built protein drugs known as DARPin® therapeutics, today announced that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to a proposed initial public offering of its American Depositary Shares ("ADSs"),...

Read more

Qrons Announces U.S. Patent Office Grants Dartmouth College 3D Printing Patent Forming Basis of License Agreement with Qrons

April 22, 2021 9:00 AM

NEW YORK, NY / ACCESSWIRE / April 22, 2021 / Qrons Inc. (OTCQB:QRON), an innovative biotechnology company developing next generation treatments for unmet neuronal diseases, using tissue engineering, stem cells and machine learning synergic technologies is proud to report that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,954,315 to the Trustees of Dartmouth College which is directed to mechanically...

Read more